Propel Bio Management, LLC Applied Therapeutics Inc. Call Options Transaction History
Propel Bio Management, LLC
- $101 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding APLT
# of Institutions
130Shares Held
112MCall Options Held
1.07MPut Options Held
800K-
Vestal Point Capital, LP New York, NY11.5MShares$7.25 Million0.58% of portfolio
-
Vr Adviser, LLC New York, NY9.99MShares$6.29 Million1.4% of portfolio
-
Morgan Stanley New York, NY8.82MShares$5.55 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY8.76MShares$5.52 Million0.05% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$4.14 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $30.3M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...